The therapeutical potency of cyanobacterial secondary metabolites compared with chemotherapy against leukemia: Mini-review - Archive ouverte HAL
Communication Dans Un Congrès Année : 2022

The therapeutical potency of cyanobacterial secondary metabolites compared with chemotherapy against leukemia: Mini-review

Résumé

Cyanobacteria are a significant group of gram-negative photosynthetic bacteria which have the ability to grow in a broad range of habitat such as lakes, oceans, soil, hot springs, deserts and so on. These photosynthetic organisms are known a potential source of bioactive compounds that can be generated as byproducts during photosynthetic process with antibacterial, anti-tumour, neuroprotective, and anti-cancer activities. So far, several cyanobacterial bioactive compounds with anti-leukemia activities have been evaluated for treatment of leukemia which is one of the most common leading cause of cancer death. However, no review study has been conducted about the anti-leukemia cyanometabolites and their therapeutic mechanisms. Therefore, this review discusses five major striking anti-leukemia cyanometabolites and their therapeutic mechanisms in summarize. Ultimately, the traditional therapeutic procedure, chemotherapy, and its common challenges and issues have been investigated to declare the superiority of natural medicines over chemotherapy.
Fichier principal
Vignette du fichier
Mousavi & Taghavi, 2022.pdf (961.48 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04608945 , version 1 (12-06-2024)

Identifiants

  • HAL Id : hal-04608945 , version 1

Citer

Shokouh Mousavi, Mohsen Taghavijeloudar. The therapeutical potency of cyanobacterial secondary metabolites compared with chemotherapy against leukemia: Mini-review. Second International Congress of Civil Engineering, Architecture, Building Materials and Environment, Nov 2022, Helsinki, Finland. ⟨hal-04608945⟩
21 Consultations
9 Téléchargements

Partager

More